RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0041-1729491
Flow-Directed Catheters in Hepatic Embolization Therapy—A Review with Clinical Cases
Abstract
Transarterial embolization with chemotherapy and radiation is well-documented forms of treatment for liver cancers but reflux of embolic particles to nontarget tissues can result in unintended consequences such as gastrointestinal ulceration. Traditionally, operators have used coil embolization of hepatoenteric collaterals to prevent reflux. Antireflux microcatheters that contain expandable baskets (Surefire) or inflatable balloons have recently been developed as tools to avoid these side effects. We describe cases where antireflux catheters were used instead of coil embolization. Using antireflux catheters, we eliminated particle reflux into nontarget vessels. We also review the literature on antireflux catheters involved in preventing reflux during chemo- and radioembolization.
Publikationsverlauf
Artikel online veröffentlicht:
18. Mai 2021
© 2021. Indian Society of Vascular and Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Mallach S, Ramp U, Erhardt A, Schmitt M, Häussinger D. An uncommon cause of gastro-duodenal ulceration. World J Gastroenterol 2008; 14 (16) 2593-2595
- 2 Ingraham CR, Johnson GE, Nair AV, Padia SA. Nontarget embolization complicating transarterial chemoembolization in a patient with hepatocellular carcinoma. Semin Intervent Radiol 2011; 28 (02) 202-206
- 3 Bhalani SM, Lewandowski RJ. Radioembolization complicated by nontarget embolization to the falciform artery. Semin Intervent Radiol 2011; 28 (02) 234-239
- 4 Hickey R, Lewandowski RJ. Hepatic radioembolization complicated by radiation cholecystitis. Semin Intervent Radiol 2011; 28 (02) 230-233
- 5 Murthy R, Brown DB, Salem R. et al. Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol 2007; 18 (04) 553-561, quiz 562
- 6 Saddekni S, Moustafa AS, Moawad S, Mahmoud K, Hamed BF, Abdel-Aal AK. Approaches for safe transarterial chemoembolization of multifocal hepatocellular carcinoma with retrograde flow in a retroportal artery. Radiol Case Rep 2017; 13 (01) 171-174
- 7 Rose SC, Kikolski SG, Chomas JE. Downstream hepatic arterial blood pressure changes caused by deployment of the surefire antireflux expandable tip. Cardiovasc Intervent Radiol 2013; 36 (05) 1262-1269
- 8 Rose SC, Halstead GD, Narsinh KH. Pressure-directed embolization of hepatic arteries in a Porcine model using a temporary occlusion balloon microcatheter: proof of concept. Cardiovasc Intervent Radiol 2017; 40 (11) 1769-1776
- 9 van den Hoven AF, Prince JF, Samim M. et al. Posttreatment PET-CT-confirmed intrahepatic radioembolization performed without coil embolization, by using the antireflux Surefire infusion system. Cardiovasc Intervent Radiol 2014; 37 (02) 523-528
- 10 Fischman AM, Ward TJ, Patel RS. et al. Prospective, randomized study of coil embolization versus Surefire infusion system during yttrium-90 radioembolization with resin microspheres. J Vasc Interv Radiol 2014; 25 (11) 1709-1716
- 11 Arepally A, Chomas J, Kraitchman D, Hong K. Quantification and reduction of reflux during embolotherapy using an antireflux catheter and tantalum microspheres: ex vivo analysis. J Vasc Interv Radiol 2013; 24 (04) 575-580
- 12 Pasciak AS, McElmurray JH, Bourgeois AC, Heidel RE, Bradley YC. The impact of an antireflux catheter on target volume particulate distribution in liver-directed embolotherapy: a pilot study. J Vasc Interv Radiol 2015; 26 (05) 660-669
- 13 Kim AY, Frantz S, Krishnan P. et al. Short-term imaging response after drug-eluting embolic trans-arterial chemoembolization delivered with the Surefire Infusion System® for the treatment of hepatocellular carcinoma. PLoS One 2017; 12 (09) e0183861
- 14 Morshedi MM, Bauman M, Rose SC, Kikolski SG. Yttrium-90 resin microsphere radioembolization using an antireflux catheter: an alternative to traditional coil embolization for nontarget protection. Cardiovasc Intervent Radiol 2015; 38 (02) 381-388
- 15 van den Hoven AF, Lam MG, Jernigan S, van den Bosch MA, Buckner GD. Innovation in catheter design for intra-arterial liver cancer treatments results in favorable particle-fluid dynamics. J Exp Clin Cancer Res 2015; 34: 74
- 16 Monsky WL, Padia SA, Hardy AH. Dual-balloon infusion microcatheter for selective drug-eluting bead transarterial chemoembolization: initial feasibility study. Diagn Interv Radiol 2017; 23 (06) 454-460
- 17 Saltarelli A, Pelle G, Notarinanni E, Pasqualini V, Cianni R, Goretti SM. Y90 radioembolization with Occlusafe catheter infusion system in patients with unresectable hepatic metastasis. J Vasc Interv Radiol 2017; 28: S213-S214
- 18 Hagspiel KD, Nambiar A, Hagspiel LM, Ahmad EA, Bozlar U. Temporary arterial balloon occlusion as an adjunct to Yttrium-90 radioembolization. Cardiovasc Intervent Radiol 2013; 36 (03) 809-813
- 19 Kim HC. Balloon-occluded transarterial chemoembolization: hot air or hot stuff?. J Vasc Interv Radiol 2019; 30 (03) 347-348